For bacteria with a polysaccharide coating, like Haemophilus influenzae type b, the best way to prevent infection is to use a<unk> . A<unk>  is a type of subunit vaccine which combines a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen. Vaccines are used to prevent diseases by invoking an immune response to an antigen, part of a bacterium or virus that the immune system recognizes. This is usually accomplished with an attenuated or dead version of a pathogenic bacterium or virus in the vaccine, so that the immune system can recognize the antigen later in life. Most vaccines contain a single antigen that the body will recognize. However, the antigen of some pathogens does not elicit a strong response from the immune system, so a vaccination against this weak antigen would not protect the person later in life. In this case, a<unk>  is used in order to invoke an immune system response against the weak antigen. In a<unk> , the weak antigen is covalently attached to a strong antigen, thereby eliciting a stronger immunological response to the weak antigen. Most commonly, the weak antigen is a polysaccharide that is attached to strong protein antigen. However, peptide/protein and protein/protein<unk> s have also been developed.
Conjugate vaccine
Synthetic vaccine
Subunit vaccine
Attenuated vaccine
Genetically modified vaccine
Inactivated vaccine
Cell-based vaccine
Heterologous vaccine